VANCOUVER, May 27
/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI,
TSX: ANP) today announced that its corporate partner, Boston Scientific
Corporation (NYSE: BSX) has...
Angiotech Pharmaceuticals, Inc. manufactures drug-coated medical devices and drug-loaded surgical implants. Its leading products are paclitaxel-eluting coronary stent designed to reduce restenosis...
Generation Drug Device and Local Delivery Medicines
Significant Progress To-Date Facilitates Early Extension and Triggers Milestone
CombinatoRx, Incorporated (NASDAQ: CRXX) and Angiotech...